News & Hightlights
Learn more about message knowledge from PlexBio
-
June 09, 2023EventsPlexBio flawlessly demonstrated the Multiplexing Diagnostics platform at Bio Boston 2023
A successful four days at BIO Boston 2023 as we shared our IntelliPlex™ platform.
Learn More -
May 25, 2023Press & MediaPlexBio™100 Fluorescent Analyzer & IntelliPlex™ 1000 πCode Processor obtained the certification of IVDR
PlexBio™100 Fluorescent Analyzer & IntelliPlex™ 1000 πCode Processor obtained the certification of IVDR.
Learn More -
February 10, 2023Press & MediaPlexBio and Denka as Strategic Partnerships Announced Successful Achievements of the Deepened Collaborations
PlexBio Co., Ltd. and Denka Co., Ltd., the biggest shareholder of PlexBio, together held a press conference to announce successful achievements since Strategic Alliance Ceremony in 2019 and plan to deepen future collaborations into infectious diseases and CDMO projects.
Learn More -
November 21, 2022EventsSuccessful Exhibition at MEDICA 2022!
We want to thank each of you for visiting PlexBio at MEDICA 2022!
Learn More
-
Press & Media
PlexBio won the "2022 Taipei Biotech Awards- Innovation Silver Medal Award
August 12, 2022
-
Press & Media
PlexBio and Denka are launching a one-step SARS-CoV-2 variant detection kit
December 15, 2021
-
-
Press & Media
FDA Grants Emergency Use Authorization for PreciGenome, PlexBio Coronavirus Tests
December 15, 2021
-
-
Press & Media
PlexBio Ranks 51 Among the Top 500 Asia-Pacific High-Growth Companies by Financial Times
December 15, 2021
-
Press & Media
PlexBio Makes the List of 2019 Deloitte Asia Pacific Technology Fast 500
December 15, 2021
-
-
Press & Media
Denka Deepens the Strategic Partnership with PlexBio Through Acquiring Over One-third of Its Stake
December 15, 2021
-
-
-
Press & Media
A. Menarini Diagnostics Signs Exclusive Supply and Distribution Agreement with PlexBio
December 15, 2021
